Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect. 2013;14:73–156.

Article  Google Scholar 

Wu C-K, Wang J-H, Lee C-H, et al. The outcome of prophylactic intravenous cefazolin and ceftriaxone in cirrhotic patients at different clinical stages of disease after endoscopic interventions for acute variceal hemorrhage. PLoS ONE. 2013;8:e61666.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alotaibi AF, Mekary RA, Zaidi HA, Smith TR, Pandya A. Safety and efficacy of antibacterial prophylaxis after craniotomy: a decision model analysis. World Neurosurg. 2017;105:906–12.e5.

Article  PubMed  Google Scholar 

Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435–86.

Article  CAS  PubMed  Google Scholar 

Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36:3075–128.

Shi C, Xiao Y, Zhang Q, et al. Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis. BMC Infect Dis. 2018;18:508.

Article  PubMed  PubMed Central  Google Scholar 

Youngster I, Shenoy ES, Hooper DC, Nelson SB. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59:369–75.

Article  CAS  Google Scholar 

Li J, Echevarria KL, Hughes DW, Cadena JA, Bowling JE, Lewis JS. Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2014;58:5117–24.

Article  PubMed  PubMed Central  Google Scholar 

Burdet C, Loubet P, Le Moing V, et al. Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial. BMJ Open. 2018;8:e023151.

Article  PubMed  PubMed Central  Google Scholar 

Shimada K, Matsuda T, Inamatsu T, Urayama K. Bleeding secondary to vitamin K deficiency in patients receiving parenteral cephem antibiotics. J Antimicrob Chemother. 1984;14(Suppl B):325–330.

Barnes T, Yan S, Kaakeh Y. Necrotizing esophagitis and bleeding associated with cefazolin. Ann Pharmacother. 2014;48:1214–8.

Article  PubMed  Google Scholar 

Gay E, Barthel A, Rouzic N, et al. Cefazolin and coagulation disorders: a case report. Ann Biol Clin (Paris). 2018;76:104–6.

CAS  PubMed  Google Scholar 

Angles E, Mouton C, Perino J, Remy A, Ouattara A. Hypoprothrombinemia and severe perioperative haemorrhagic complications in cardiac surgery patients treated with high-dose cefazolin for infective endocarditis. Anaesth Crit Care Pain Med. 2018;37:167–70.

Article  PubMed  Google Scholar 

Résumé des caractéristiques du produit - CEFAZOLINE VIATRIS 1 g, poudre pour solution injectable (IM-IV) - Base de données publique des médicaments. https://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=61242331&typedoc=R. Accessed 28 Nov 2022.

Shearer MJ, Bechtold H, Andrassy K, et al. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol. 1988;28:88–95.

Article  CAS  PubMed  Google Scholar 

Wood TC, Johnson KL, Naylor S, Weinshilboum RM. Cefazolin administration and 2-methyl-1,3,4-thiadiazole-5-thiol in human tissue: possible relationship to hypoprothrombinemia. Drug Metab Dispos Biol Fate Chem. 2002;30:1123–8.

Article  CAS  PubMed  Google Scholar 

Strazzulla A, Chakvetadze C, Picque M, et al. Evolution of haemostatic parameters and risk of bleeding during treatment with cefazolin. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2019;38:177–83.

Article  CAS  Google Scholar 

Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daniel W. Biostatistics: a foundation for analysis in the health sciences. New York: Wiley; 1999.

Google Scholar 

Guilhaumou R, Benaboud S, Bennis Y, et al. Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation-SFAR). Crit Care Lond Engl. 2019;23:104.

Article  Google Scholar 

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.

Article  PubMed  Google Scholar 

Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692–4.

Kaatz S, Ahmad D, Spyropoulos AC, Schulman S, Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13:2119–26.

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies—PubMed. https://pubmed.ncbi.nlm.nih.gov/18064739/. Accessed 23 Nov 2022.

Rao SN, Rhodes NJ, Lee BJ, et al. Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2015;59:5232–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Twilla JD, Algrim A, Adams EH, Samarin M, Cummings C, Finch CK. Comparison of nafcillin and cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia. Am J Med Sci. 2020;360:35–41.

Article  PubMed  Google Scholar 

Chien T-L, Hsiao F-Y, Chen L-J, Wen Y-W, Lin S-W. Development and validation of a risk scoring system for cephamycin-associated hemorrhagic events. Sci Rep. 2019;9:12905.

Article  PubMed  PubMed Central  Google Scholar 

Wang W, Liu Y, Yu C, et al. Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study. Expert Opin Drug Saf. 2020;19:339–47.

Article  CAS  PubMed  Google Scholar 

Raine J, Spooner A. Minutes from the meeting on 30 August–02 September 2016. 2016.

Abbas S, Ihle P, Harder S, Schubert I. Risk of bleeding and antibiotic use in patients receiving continuous phenprocoumon therapy. A case-control study nested in a large insurance- and population-based German cohort. Thromb Haemost. 2014;111:912–922.

Siguret V, Pautas E, Gouin-Thibault I. Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin. Vitam Horm. 2008;78:247–64.

Article  CAS  PubMed  Google Scholar